News
2d
MedPage Today on MSNNovel Drug May Help Speed Kids' GI Recovery in Severe Post-COVID SyndromeYonker is a co-inventor on a patent for zonulin antagonists to treat MIS-C, as are two other co-authors. Co-authors also ...
And part of that strategy seems to be owning some of the more controversial moves he made as governor during the COVID-19 ...
In a small trial, Mass General Brigham researchers have found that a drug designed to treat celiac disease supported a more ...
COVID-19 activity is rising in much of the country. Data released Friday by federal health officials shows overall ...
Shuhiba Mohammad recently took her daughter for her routine childhood immunizations at age 1, and was frustrated when she was ...
Larazotide, a therapy known to treat celiac disease, shows promise as a safe treatment for multisystem inflammatory syndrome in children linked to COVID-19, enhancing recovery and symptom resolution.
Living through the pandemic aged our brains faster — even among people who never became sick with COVID-19, according to a ...
Increases in COVID, RSV, and influenza are the result of governments refusal to enact public health measures and address ...
2d
News-Medical.Net on MSNExperimental drug found to be safe and effective in treating children with MIS-CIn a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid ...
In a new analysis of the RECOVER-Adult cohort, Mass General Brigham researchers found a two- to three-times higher risk of long COVID in those with social risk factors, including financial hardship, ...
The COVID-19 pandemic upended life for individuals and communities worldwide. Social isolation, health mandates, illness, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results